Skip to main content

Table 2 Completeness of microbiology testing and frequency of positive test result among 162 SARS-CoV-2 hospitalized patients

From: Community-acquired and hospital-acquired respiratory tract infection and bloodstream infection in patients hospitalized with COVID-19 pneumonia

 

All (n = 162)

Non-ICU (n = 121)

ICU-patients (n = 41)

Individuals tested, n (%)

Positive test/tested, n (%)

Individuals tested, n (%)

Positive test/tested, n (%)

Individuals tested, n (%)

Positive test/ tested, n (%)

BIOFIRE® FILMARRAY® Respiratory 2 plus Panel

87/162 (53.7)

5/87 (5.7)

62/121 (51.2)

4/62 (6.5)

25/41 (61.0)

1/25 (4.0)

Respiratory cultureb (n = 184 samples)

35/162 (21.6)

19/35 (54.3)

9/121 (7.4)

4/9 (44.4)

26/41 (63.4)

15/26 (57.7)

Legionella pneumophila (urinary antigen)

60/162 (37.0)

0

32/121 (26.4)

0

28/41 (68.3)

0

Streptococcus pneumonia (urinary antigen)

48/162 (29.6)

1/48 (2.1)

25/121 (20.7)

0

23/41 (56.1)

1/23 (4.3)

Blood culture (n = 1110 bottles)

127/162 (78.4)

20/127 (15.7)

88/121 (72.7)

11/88 (12.5)

39/41 (95.1)

10/39 (25.6)

  1. aA positive test result was not equal to clinical infection
  2. bRespiratory samples included: tracheal secrete (n = 136), sputum (n = 25), bronchoalveolar lavage (n = 11), and bronchial secrete (n = 12)